Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor

We report the case of a 75-year-old woman with a pancreatic body mass. Pathological findings from endoscopic ultrasonography-guided fine-needle aspiration revealed medullary carcinoma of the pancreas (MCP). Deficient mismatch repair (dMMR) and high microsatellite instability (MSI-H) were identified through immunohistochemistry and next generation sequencing, respectively. While immunohistochemistry suggested MLH1 abnormality, no <i>MLH1</i> mutation was; hypermethylation of the <i>MLH1</i> promoter was later confirmed via bisulfite sequencing. The patient initially received nab-paclitaxel plus gemcitabine, achieving tumor shrinkage. Upon tumor regrowth, she was treated with the anti-programmed cell death-1 immune checkpoint inhibitor (ICI) pembrolizumab, which resulted in significant tumor reduction. This is the first case report of MCP with dMMR/MSI-H due to <i>MLH1</i> promoter hypermethylation, effectively treated with an ICI.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-03-27
DOI
https://doi.org/10.3389/fonc.2025.1551038
Citations
1
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor

Kazuhiro Miwa, Akihiro Nishiyama, Yoshiaki Nakamura, Dai Inoue et al.
1 citations
Frontiers in Oncology
Pancreatic and Hepatic Oncology Research
1.05
article

Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor

Kazuhiro Miwa, Akihiro Nishiyama, Yoshiaki Nakamura, Dai Inoue, Atsushi Watanabe, Hiroshi Kotani, Fumihito Toshima, Shinji Takeuchi, Hiroyuki Sakaguchi, Kunio Miyake, Takayuki Yoshino, Kenji Notohara, Takao Fujisawa, Koushiro Ohtsubo, Seiji Yano, Toshifumi Gabata, Hiroko Ikeda, Kaname Yamashita, Shigeki Sato
article en
1 citations

Abstract

We report the case of a 75-year-old woman with a pancreatic body mass. Pathological findings from endoscopic ultrasonography-guided fine-needle aspiration revealed medullary carcinoma of the pancreas (MCP). Deficient mismatch repair (dMMR) and high microsatellite instability (MSI-H) were identified through immunohistochemistry and next generation sequencing, respectively. While immunohistochemistry suggested MLH1 abnormality, no <i>MLH1</i> mutation was; hypermethylation of the <i>MLH1</i> promoter was later confirmed via bisulfite sequencing. The patient initially received nab-paclitaxel plus gemcitabine, achieving tumor shrinkage. Upon tumor regrowth, she was treated with the anti-programmed cell death-1 immune checkpoint inhibitor (ICI) pembrolizumab, which resulted in significant tumor reduction. This is the first case report of MCP with dMMR/MSI-H due to <i>MLH1</i> promoter hypermethylation, effectively treated with an ICI.

Frontiers in OncologyVol. 15
Kurashiki Central Hospital (JP), Kanazawa University Hospital (JP), Kanazawa Medical University Hospital (JP), National Cancer Center Hospital East (JP), University of Yamanashi (JP), Komatsu (Japan) (JP)
Good health and well-being
Openalex Percentile: Top 24%
Pancreatic and Hepatic Oncology Research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.